BRIACELL THERAPEUTICS CORP - COM NEW (BCTX)

CUSIP: 10778Y302

Q2 2023 13F Holders as of 30 Jun 2023

Share change
+174,830
SEC-reported price per share
$6.42
Number of holders
20
Value change
+$1,133,051
Number of buys
10
Number of sells
10

Security key

10778Y302

Report period

Q2 2023

Institutions

20

Top holders

10

Ownership snapshot

Top reported holders of BCTX - BRIACELL THERAPEUTICS CORP - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Lynwood Capital Managemen...
Disclosed value leader
Lynwood Capital Managemen...
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F 3/4/5 Highest disclosed value: $11,398,500 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Lynwood Capital Management Inc. has the largest disclosed position value at $11.4M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Lynwood Capital Management Inc.'s linked filing trail.
Disclosed position value Top 5
Lynwood Capital Management Inc. $11.4M
WASATCH ADVISORS LP $4.59M
K.J. Harrison & Partners Inc $1.29M
Redmond Asset Management, LLC $1.24M
ARMISTICE CAPITAL, LLC $1.11M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Lynwood Capital Management Inc.
13F
Company
13F
—
denominator unverified
$11,398,500
1,530,000 shares
— 31 Mar 2023
WASATCH ADVISORS LP
13F
Company
13F
—
denominator unverified
$4,589,781
616,078 shares
— 31 Mar 2023
K.J. Harrison & Partners Inc
13F
Company
13F
—
mixed-class rows
$1,290,544
276,683 shares
mixed-class rows
— 31 Mar 2023
Redmond Asset Management, LLC
13F
Company
13F
—
mixed-class rows
$1,238,783
212,689 shares
mixed-class rows
— 31 Mar 2023
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$1,110,000
375,001 shares
— 31 Mar 2023
Jamieson Bondarenko
3/4/5
Chairman, Director
—
denominator unverified
$777,940
169,856 shares
— 28 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
20
Shares
2,777,510
Rows available
20
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
21
Q2 2023 holders
20
Holder diff
-1
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .